Rocket


News + Filings
Transactions





Sigal Charles Elliott

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
07/03/2023Adaptimmune Therapeutics PLCADAPGrantOption to purchase Ordinary Shares933.3k$0.00$0 07/03/2023
05/22/2023Vir Biotechnology, Inc.VIRGrantStock Option (Right to Buy)12.1k$25.74$310.3k 05/22/2023
05/22/2023Vir Biotechnology, Inc.VIRGrantCommon Stock6k$0.00$0 05/22/2023
05/18/2023ALNYLAM PHARMACEUTICALS, INC.ALNYGrantStock Option (right to buy)3.5k$189.87$655.8k 05/18/2023
03/01/2023Vir Biotechnology, Inc.VIRPurchaseCommon Stock2.5k$22.73$56.8kBy Sigal Family Investments, LLC03/01/2023
01/04/2023Vir Biotechnology, Inc.VIRPurchaseCommon Stock2.5k$25.25$63.1kBy Sigal Family Investments, LLC01/03/2023
01/03/2023Vir Biotechnology, Inc.VIRPurchaseCommon Stock2.5k$25.60$64kBy Sigal Family Investments, LLC01/03/2023
08/22/2022ALNYLAM PHARMACEUTICALS, INC.ALNYGrantStock Option (right to buy)4.5k$217.91$971k 08/22/2022
07/01/2022Adaptimmune Therapeutics PLCADAPGrantOption to purchase Ordinary Shares737k$0.00$0 07/01/2022
06/08/2022Surface Oncology, Inc.SURFGrantStock Option (Right to Buy)24k$2.01$48.2k 06/08/2022
05/23/2022Vir Biotechnology, Inc.VIRGrantStock Option (Right to Buy)12.8k$24.14$309.2k 05/23/2022
05/23/2022Vir Biotechnology, Inc.VIRGrantCommon Stock6.4k$0.00$0 05/23/2022
07/01/2021Adaptimmune Therapeutics PLCADAPGrantOption to purchase Ordinary Shares474.4k$0.00$0 07/01/2021
06/08/2021Surface Oncology, Inc.SURFGrantStock Option (Right to Buy)17.7k$7.69$136.1k 06/08/2021
05/21/2021Vir Biotechnology, Inc.VIRGrantStock Option (Right to Buy)6.7k$45.28$305.5k 05/21/2021
05/21/2021Vir Biotechnology, Inc.VIRGrantCommon Stock3.4k$0.00$0 05/21/2021
07/10/2020Vir Biotechnology, Inc.VIRGrantStock Option (Right to Buy)57.8k$48.71$2.8M 07/10/2020
07/10/2020Vir Biotechnology, Inc.VIRGrantStock Option (Right to Buy)28.4k$48.71$1.4M 07/10/2020
07/01/2020Adaptimmune Therapeutics PLCADAPGrantOption to purchase Ordinary Shares184.3k$0.00$0 07/01/2020
06/10/2020Surface Oncology, Inc.SURFGrantStock Option (Right to Buy)12k$4.35$52.2k 06/10/2020
10/01/2019Surface Oncology, Inc.SURFGrantStock Option (Right to Buy)13.6k$1.17$15.9k 10/01/2019
07/02/2019Adaptimmune Therapeutics PLCADAPGrantOption to purchase Ordinary Shares234.4k$0.00$0 07/02/2019
06/05/2019Surface Oncology, Inc.SURFGrantStock Option (Right to Buy)12.1k$3.69$44.6k 06/05/2019
07/02/2018Surface Oncology, Inc.SURFGrantStock Option (Right to Buy)8.9k$16.83$149.5k 07/02/2018
06/22/2018Adaptimmune Therapeutics PLCADAPGrantOption to purchase Ordinary Shares154.8k$0.00$0 06/22/2018
04/23/2018Surface Oncology, Inc.SURFConversionCommon Stock45.5k$0.00$0See Footnote04/23/2018
04/23/2018Surface Oncology, Inc.SURFConversionSeries A Preferred Stock100k$0.00$0See Footnote04/23/2018
07/03/2017Adaptimmune Therapeutics PLCADAPGrantOption to purchase Ordinary Shares220.8k$0.00$0 07/03/2017

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy